AcelRx Announces $14 Million Registered Direct Common Stock and Warrant Offering
- Monday, November 15, 2021, 7:01
- Finance
- Add a comment
HAYWARD, Calif., Nov. 15, 2021 /PRNewswire/ — AcelRx Pharmaceuticals, Inc. (NASDAQ: ACRX) (AcelRx), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for use in medically supervised settings, today announced it has entered into an…
About the Author
adminasapcorp has written 41790 stories on this site.